These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25751824)

  • 1. Aspergillus, angiogenesis, and obesity: the story behind beloranib.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2015 Mar; 53(3):13-6. PubMed ID: 25751824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascending dose-controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women.
    Hughes TE; Kim DD; Marjason J; Proietto J; Whitehead JP; Vath JE
    Obesity (Silver Spring); 2013 Sep; 21(9):1782-8. PubMed ID: 23512440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial.
    Kim DD; Krishnarajah J; Lillioja S; de Looze F; Marjason J; Proietto J; Shakib S; Stuckey BGA; Vath JE; Hughes TE
    Diabetes Obes Metab; 2015 Jun; 17(6):566-572. PubMed ID: 25732625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fumagillin reduces adipose tissue formation in murine models of nutritionally induced obesity.
    Lijnen HR; Frederix L; Van Hoef B
    Obesity (Silver Spring); 2010 Dec; 18(12):2241-6. PubMed ID: 20094042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the anti-obesity effects of the TNP-470 analog, CKD-732.
    Kim YM; An JJ; Jin YJ; Rhee Y; Cha BS; Lee HC; Lim SK
    J Mol Endocrinol; 2007 Apr; 38(4):455-65. PubMed ID: 17446235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of methionine aminopeptidase 2 inhibition in type 2 diabetes: a randomised, placebo-controlled clinical trial.
    Proietto J; Malloy J; Zhuang D; Arya M; Cohen ND; de Looze FJ; Gilfillan C; Griffin P; Hall S; Nathow T; Oldfield GS; O'Neal DN; Roberts A; Stuckey BGA; Yue D; Taylor K; Kim D
    Diabetologia; 2018 Sep; 61(9):1918-1922. PubMed ID: 29992370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, placebo-controlled trial of beloranib for the treatment of hypothalamic injury-associated obesity.
    Shoemaker A; Proietto J; Abuzzahab MJ; Markovic T; Malloy J; Kim DD
    Diabetes Obes Metab; 2017 Aug; 19(8):1165-1170. PubMed ID: 28261955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fumagillin: an anti-infective as a parent molecule for novel angiogenesis inhibitors.
    Lefkove B; Govindarajan B; Arbiser JL
    Expert Rev Anti Infect Ther; 2007 Aug; 5(4):573-9. PubMed ID: 17678422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial.
    McCandless SE; Yanovski JA; Miller J; Fu C; Bird LM; Salehi P; Chan CL; Stafford D; Abuzzahab MJ; Viskochil D; Barlow SE; Angulo M; Myers SE; Whitman BY; Styne D; Roof E; Dykens EM; Scheimann AO; Malloy J; Zhuang D; Taylor K; Hughes TE; Kim DD; Butler MG
    Diabetes Obes Metab; 2017 Dec; 19(12):1751-1761. PubMed ID: 28556449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust Reductions of Excess Weight and Hyperphagia by Beloranib in Rat Models of Genetic and Hypothalamic Obesity.
    Elfers CT; Roth CL
    Endocrinology; 2017 Jan; 158(1):41-55. PubMed ID: 27849360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Horizons in the Pharmacotherapy of Obesity.
    Arch JR
    Curr Obes Rep; 2015 Dec; 4(4):451-9. PubMed ID: 26346394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth.
    Ingber D; Fujita T; Kishimoto S; Sudo K; Kanamaru T; Brem H; Folkman J
    Nature; 1990 Dec; 348(6301):555-7. PubMed ID: 1701033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and emerging medications for overweight or obesity in people with comorbidities.
    Fujioka K
    Diabetes Obes Metab; 2015 Nov; 17(11):1021-32. PubMed ID: 26040215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fumagillin: an overview of recent scientific advances and their significance for apiculture.
    van den Heever JP; Thompson TS; Curtis JM; Ibrahim A; Pernal SF
    J Agric Food Chem; 2014 Apr; 62(13):2728-37. PubMed ID: 24621007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On chance discovery in rational drug design. Aspergillus fumigatus and angiogenesis].
    Klein C
    Pharm Unserer Zeit; 2007; 36(6):450-1. PubMed ID: 17957690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Efficacy and Safety of the Novel Antidiabetic, Antiobesity MetAP2 Inhibitor ZGN-1061.
    Burkey BF; Hoglen NC; Inskeep P; Wyman M; Hughes TE; Vath JE
    J Pharmacol Exp Ther; 2018 May; 365(2):301-313. PubMed ID: 29491038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of novel fumagillin and ovalicin analogues.
    Mazitschek R; Huwe A; Giannis A
    Org Biomol Chem; 2005 Jun; 3(11):2150-4. PubMed ID: 15917904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fumagillin on adipocyte differentiation and adipogenesis.
    Scroyen I; Christiaens V; Lijnen HR
    Biochim Biophys Acta; 2010 Apr; 1800(4):425-9. PubMed ID: 19961899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent.
    Kusaka M; Sudo K; Fujita T; Marui S; Itoh F; Ingber D; Folkman J
    Biochem Biophys Res Commun; 1991 Feb; 174(3):1070-6. PubMed ID: 1705118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fumagillin and fumarranol interact with P. falciparum methionine aminopeptidase 2 and inhibit malaria parasite growth in vitro and in vivo.
    Chen X; Xie S; Bhat S; Kumar N; Shapiro TA; Liu JO
    Chem Biol; 2009 Feb; 16(2):193-202. PubMed ID: 19246010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.